Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?

被引：0
|
作者：
Scott, Stuart A. [1 ]
Lubitz, Steven A. [2 ,3 ,4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
[2] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA 02114 USA
来源：
PHARMACOGENOMICS | 2014年 / 15卷 / 06期
关键词：
clinical utility; CYP2C9; pharmacogenetics; pharmacogenomics; randomized controlled clinical trial; VKORC1; warfarin; RANDOMIZED-TRIAL; AMERICAN-COLLEGE; THERAPY; ASSOCIATION; INITIATION; CYP2C9;
D O I：
10.2217/PGS.14.18
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：719 / 722
页数：4
相关论文
共 50 条
  • [1] Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin
    Verhoef, Talitha I.
    Schalekamp, Tom
    Redekop, William K.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 375 - 378
  • [2] Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans
    Alzubiedi, Sameh
    Saleh, Mohammad I.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (01) : 86 - 92
  • [3] Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
    Verhoef, Talitha I.
    Redekop, William K.
    Daly, Ann K.
    van Schie, Rianne M. F.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 626 - 641
  • [4] Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients
    Ramos, Alga S.
    Seip, Richard L.
    Rivera-Miranda, Giselle
    Felici-Giovanini, Marcos E.
    Garcia-Berdecia, Rafael
    Alejandro-Cowan, Yirelia
    Kocherla, Mohan
    Cruz, Iadelisse
    Feliu, Juan F.
    Cadilla, Carmed L.
    Renta, Jessica Y.
    Gorowski, Krystyna
    Vergara, Cunegundo
    Ruano, Gualberto
    Duconge, Jorge
    [J]. PHARMACOGENOMICS, 2012, 13 (16) : 1937 - 1950
  • [5] Cost-Effectiveness Analysis of Pharmacogenetic-Guided Warfarin Dosing in Thailand
    Chong, Huey Yi
    Saokaew, Surasak
    Dumrongprat, Kuntika
    Permsuwan, Unchalee
    Wu, David Bin-Chia
    Sritara, Piyamitr
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 : S2 - S2
  • [6] Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
    Chong, Huey Yi
    Saokaew, Surasak
    Dumrongprat, Kuntika
    Permsuwan, Unchalee
    Wu, David Bin-Chia
    Sritara, Piyamitr
    Chaiyakunapruk, Nathorn
    [J]. THROMBOSIS RESEARCH, 2014, 134 (06) : 1278 - 1284
  • [7] Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
    Verhoef, T. I.
    Redekop, W. K.
    Langenskiold, S.
    Kamali, F.
    Wadelius, M.
    Burnside, G.
    Maitland-van der Zee, A-H
    Hughes, D. A.
    Pirmohamed, M.
    [J]. PHARMACOGENOMICS JOURNAL, 2016, 16 (05): : 478 - 484
  • [8] Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
    Pei, Lin
    Tian, Xiaoyi
    Long, Yan
    Nan, Wenhui
    Jia, Mei
    Qiao, Rui
    Zhang, Jie
    [J]. MEDICINE, 2018, 97 (36)
  • [9] Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
    T I Verhoef
    W K Redekop
    S Langenskiold
    F Kamali
    M Wadelius
    G Burnside
    A-H Maitland-van der Zee
    D A Hughes
    M Pirmohamed
    [J]. The Pharmacogenomics Journal, 2016, 16 : 478 - 484
  • [10] Focus group testing of a mobile app for pharmacogenetic-guided dosing
    Dodson, Crystal Heath
    Baker, Elizabeth
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2021, 33 (03) : 205 - 210
12345